C opy r ig h t 2 0 0 0 b y Th e A mer ic a n S oc iet y f or B ioc h emist r y a nd M ol ec u l a r B iol og y , I nc . The important human pathogen Streptococcus pneumoniae was found to absorb factor H, an inhibitor of complement, from human plasma. We identified the gene encoding a novel surface protein, factor H-binding inhibitor of complement (Hic), in the pspC locus of type 3 pneumococci. Unlike PspC proteins in other serotypes, Hic is anchored to the cell wall by means of an LPXTG motif, and the overall sequence homology to various PspC proteins is low.
INTRODUCTION
Despite the availability of effective antibiotics and a polyvalent capsular polysaccharide vaccine, Streptococcus pneumoniae remains a significant cause of morbidity and mortality, causing conditions such as otitis media, community-acquired pneumonia, septicemia and meningitis.
Infants, the elderly, and immunocompromised patients are particularly susceptible to pneumococcal infection.
The polysaccharide capsule of the pneumococcus has long been recognized as the major virulence determinant (1) . Virulence varies with capsular serotype, but experiments with conversion of serotypes clearly demonstrate that other factors than the capsule play a significant role (2) . A number of non-capsular virulence factors have also been extensively examined. Although their relative contribution to pneumococcal virulence remains unclear, it is apparent that proteins such as PspA 1 , pneumolysin, and PsaA play a role in pneumococcal virulence (3) (4) (5) .
The classical and alternative pathways of complement are part of the innate immune system, and constitute an important line of defense against pneumococcal infection (6, 7) . There are many strategies by which bacteria can interfere with the function of the complement system (reviewed in (8) ). For example, binding of the complement regulatory protein fH to bacterial surface proteins has been described by several groups (reviewed in (9) ), although the precise consequences of such a binding remain somewhat elusive. fH is a 150 kDa plasma protein composed of 20 short consensus repeats, and is the best characterized member of the factor H protein family (10) . fH is a crucial protein in the regulation of complement. The critical step in the amplification loop of the alternative pathway is the formation of C3 convertase (C3bBb) from 4
Examples of bacterial surface structures interacting with fH include M and M-like proteins of S.
pyogenes (11, 12) . Furthermore, YadA in Yersinia enterocolitica has been shown to inhibit complement activation by coating the bacterial surface with fH (13) . Recently, two groups independently described inhibition of complement-mediated opsonophagocytosis in type 3 pneumococci. One study (14) suggested that PspA interferes with deposition of C3b and/or inhibits the alternative pathway C3 convertase. Another study (15) claimed that pneumococcal resistance to phagocytosis is mediated by hitherto unknown surface proteins binding fH. PspA
does not contribute to this interaction, as a PspA-deficient mutant bound similar or even larger amounts of fH than the parent strain.
In this study we expand upon previous works on pneumococci and complement by describing a novel surface protein containing a fH-binding region. The protein was identified in silico by using previously described fH-binding proteins as probes, and the candidate gene was found in the chromosomal locus of PspC (also called SpsA, PbcA and CbpA). A recent paper compares different allelic variants of PspC (16) in several pneumococcal serotypes, and previous works have suggested functions for PspC such as binding of secretory IgA (17) , or influence on adhesion and virulence (18) . Interestingly, the protein we describe differs substantially from all previously described PspC alleles, except for the amino terminal region. Our data show that this region is responsible for fH binding in type 3 pneumococci, and suggest that fH binding to other serotypes is mediated by PspC regions homologous to this domain. Oligonucleotides HICf1 (5'-TGGGATCCCAGAGAAGGAGGTAAC TAC-3') and HICr1 (5'-GGAGCCTGAATTCGACGAAG-3'), containing BamHI and EcoRI restriction sites respectively, were used in a polymerase chain reaction (PCR) to amplify DNA corresponding to amino acids 39 to 261 in Hic. The PCR was performed with Taq polymerase (Gibco BRL), and consisted of 30 cycles at 94°C for 1 min., 50°C for 1 min., and 72°C for 1 min., followed by a final extension at 72°C for 7 min. Template was prepared by resuspending bacterial colonies in water, boiling for 5 min., and removal of bacterial debris by centrifuging at 13000 x g. The PCRamplified fragment was gel-purified with Sephaglas Bandprep (Pharmacia Biotech), digested with
EXPERIMENTAL PROCEDURES
BamHI and EcoRI (Pharmacia Biotech) and ligated with likewise digested vector pGEX-5X-3 (Pharmacia Biotech) using T4 DNA ligase (Pharmacia Biotech). Plasmid pGEX-5X-3:hic(39-261) was then electroporated into DH5α E. coli according to the GST gene fusion system protocol (Pharmacia Biotech). Transformants were screened for presence of insert by plasmid mini-preps 6 and restriction enzyme digestion. The clone used for overexpression of the fusion protein GST:Hic 39-261 was verified by purifying the plasmid and sequencing the complete insert. Fusion protein was affinity purified according to the instructions in the GST gene fusion system manual (Pharmacia Biotech).
Ligand binding and protein methods
Plasma absorption experiments were performed with log-phase pneumococci (OD 600 ∼0.4).
Bacteria were washed twice in PBS, pH 7.4, containing 0.05 % Tween 20 (PBST), and the bacterial concentration was adjusted to 2 x 10 10 cells/ml. 100 µl of bacteria were incubated for 1 h with 100 µl of human plasma. Bacteria were washed five times with PBST, and bound proteins were eluted from the cells with 100 µl 0.1 M glycine/HCl, pH 2.0. (10µg/ml), followed by injection of fH (2 -0.127 µM). The kinetic studies were performed in PBST. Each cycle was terminated by the regeneration of the chip with 10 mM glycine pH 2.2.
Global analysis of data was performed with multiple models in BiaEvaluation 3.0.
Hemolysis assay
A previously described assay for the measurement of fH-mediated inhibition of the alternative pathway was employed (24 
RESULTS

Binding of complement factor H by S. pneumoniae
Previous observations in our laboratory indicated that S. pneumoniae is capable of absorbing proteins from human plasma (unpublished results). To better investigate the nature of these interactions, a series of strains (Table 1) , both encapsulated and unencapsulated, was incubated with plasma. After washing, plasma proteins bound to the pneumococci were eluted and separated by polyacrylamide gel electrophoresis (PAGE), showing that strains D39 (type 2, encapsulated), and all four unencapsulated strains (serotypes 2, 3, 3, and 19) absorbed a protein with an estimated molecular mass of 140 kDa ( Fig. 1, STAIN) . In repeated experiments PR218, an unencapsulated derivative (Pearce, Iannelli and Pozzi, manuscript in preparation) of Avery strain A66, consistently showed the most prominent absorption of the 140 kDa protein. The protein absorbed by PR218 was subjected to trypsin-in-gel digestion, and six internal fragments were sequenced by Edman degradation. These sequences showed 100% identity to various 9 regions in human complement factor H. A replica of the gel in Fig. 1 was transferred to a membrane by electroblotting, and probed with a rabbit anti-fH antiserum. The antiserum reacted with the aforementioned 140 kDa band, a band of similar size in plasma, and purified fH ( Fig. 1,   BLOT ). There was also a weak reactivity with a band corresponding to ∼50 kDa. When subjected to NH 2 -terminal sequencing, the band was identified as human immunoglobulin heavy chains, suggesting specific or unspecific binding of immunoglobulins to pneumococci, and subsequent crossreactivity with the secondary goat anti-rabbit antibodies.
To exclude that binding of fH was secondary to complement activation and deposition of C3 at the bacterial surface, the plasma absorption with strain D39 was repeated using a C3-deficient serum. The protein reacting with anti-fH antibodies was present in equal amounts when comparing results from absorptions of normal human plasma and the C3-deficient serum (data not shown), showing that fH binding is independent of C3.
A group of S. pneumoniae strains was examined for binding of radiolabelled fH. Most strains showed significant binding of fH, although the degree of binding varied considerably between strains ( Table 2) . Encapsulated strains generally bound somewhat less than the corresponding unencapsulated strains. To investigate whether the binding was mediated by proteinaceous structures, binding of fH to strain PR218 was examined following treatment of bacteria with different proteases (data not shown). Binding was almost completely abolished by pretreatment with papain. Trypsin also caused a major decrease, whereas pepsin had a moderate effect (<50% decrease). These results confirm a previous observation (15) 
Construction and properties of a Hic-deficient mutant strain
To investigate the possible contribution of Hic to pneumococcal fH-binding, the unencapsulated strain PR218 (serotype 3), showing the most pronounced absorption of fH from human plasma, was chosen for further studies. Splicing by overlap extension (gene SOEing) (19) was used to flank an antibiotic resistance cassette with sequences found up-and downstream of the hic gene.
PR218 was transformed with this construct and the hic gene was deleted by double cross-over mutagenesis. The resulting strain, FP13, grew as well as the parent strain in ordinary growth media. The deletion of hic was confirmed by PCR experiments.
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The mutant strain was subjected to plasma absorption experiments identical to those described above. In contrast to the parent strain ( Fig. 1) , no band at the position of fH was detected with the anti-fH antiserum. Furthermore, the binding of radiolabelled fH to wild type and mutant bacteria was examined using serial dilutions of bacteria (Fig. 4) . Unlike the parent strain PR218, the mutant strain FP13 showed background levels of fH binding even at the highest bacterial concentration. The possible contribution of PspC to pneumococcal fH binding was also examined by constructing a mutant derivative of D39, where the pspC gene has been truncated so that the 405 NH 2 -terminal amino acids are missing in PspC. This mutant, called FP7, was used in plasma absorption experiments, and no band reacting with the anti-fH antibodies was eluted (data not shown).
Mapping of the factor H-binding region of Hic
We decided to investigate the binding properties of the non-repeat region of Hic, including the part shared by Hic, PspC, CbpA, SpsA, and PbcA. Therefore, the hic region encoding the NH 2 -terminal part of Hic (aa 39 -261) was cloned into the vector pGEX, resulting in a fusion with the gene encoding GST. Control sequencing of the insert verified the presence of the partial hic gene,
showing 100 % identity with the DNA sequence from strain A66. GST:Hic 39-261 and GST were overexpressed, affinity purified, and analysed by SDS-PAGE (Fig. 5A, STAIN) . Although partly degraded, the main protein band had the expected mass (54 kDa). An identical gel was blotted to a membrane, which was then incubated with radiolabelled fH, washed, and subjected to autoradiography. fH bound to GST:Hic 39-261 , but not to GST (Fig. 5A, BLOT) . The fusion protein and the GST control were also applied in serial dilutions onto a nitrocellulose membrane.
The membrane was probed with radiolabelled fH, which showed binding to the fusion protein, and no binding to GST (Fig. 5B) blocked the binding of fH to the tested strains, whereas GST had no effect (data not shown). The G54 strain is of serotype 19, and the similarity between Hic and PspC of a type 19
pneumococcus (see Fig. 2B ) implicates that fH binding to non type 3 strains is mediated by the PspC region homologous to Hic.
The interaction between GST:Hic 39-261 and fH was further examined by surface plasmon resonance. Anti-GST antibodies were coupled to a carboxymethyldextrane chip, followed by the 
Hic and complement inhibition
From a functional point of view, an important question is whether the binding of Hic to fH affects the complement inhibitory function of fH. To address this issue we adapted a previously described methodology where complement-mediated lysis of rabbit erythrocytes in serum is was added (Fig. 7) .
DISCUSSION
Complement-dependent opsonophagocytosis is a crucial defense against infection with
Streptococcus pneumoniae (33) . Two recent studies discuss how type 3 pneumococci may subvert the normal function of the complement system. One study (14) showed that the alternative pathway of complement is essential for efficient clearance of bacteria, and that pneumococcal interference with complement activation is a virulence determinant. Based on comparisons of PspA-negative mutants with wild type bacteria the researchers claim that PspA blocks recruitment of the alternative pathway, by an unknown mechanism. Another study (15) describes the binding of complement factor H to trypsin-sensitive structures at the surface of pneumococci, independent of previous activation of complement. Notably, the study rules out expressed Hic fragment, is responsible for factor H binding in many pneumococcal strains. It has previously been shown that PspC is a protective antigen, and the NH 2 -terminal region probably has to undergo significant genetic variation in order to avoid eliciting specific antibodies. This, however, does not preclude specific binding of fH. In comparison, the M5 and M6 proteins of S.
pyogenes have been shown to bind factor H-like protein 1 by their hypervariable region (12) .
Similarily, several M-like proteins bind another complement regulatory protein, C4 binding protein (34) , by the hypervariable NH 2 -terminal region. We found that a type 2 mutant strain that expressed an NH 2 -terminally truncated form of PspC failed to absorb fH from plasma, unlike the parent strain D39. Although not conclusive, since the truncation also involved a part of PspC that shows no homology with Hic, this experiment supports the idea that fH binding could be mediated by the NH 2 -terminal regions of both PspC and Hic.
Many studies have showed that interference with the function of the complement system is a highly relevant aspect of pneumococcal virulence. More specifically, the binding of fH has been shown to correlate with resistance to opsonophagocytosis. A previous study showed that type 3 pneumococci, despite C3b deposition on both cell wall and capsule, strongly resist phagocytosis (29) . Our data show that hic, a highly atypical pspC allele, encodes the major fH-binding protein of type 3 pneumococci. The complement inhibitory function of fH is not impaired in the presence of Hic. By accumulating an active complement inhibitor at the pneumococcal surface, Hic may act alone or in concert with PspA to block deposition of C3b and concomitant opsonophagocytosis. As previously described, a putative C3 proteinase in types 3, 4 and 14 pneumococci (35) should have similar effects. The present findings also indicated that Hic could have an intrinsic capacity to inhibit the alternative pathway. One possibility is that complex formation with Hic potentiated the inherent function of fH, as fH was present in the diluted C2-deficient serum used in the hemolytic assay. Interactions between Hic and other components of the alternative pathway may also be considered, perhaps by binding to short consensus repeats.
In conclusion, pneumococci appear highly prone to interfere with the complement system. Binding of fH, by different mechanisms, has also been described for group A streptococci (11), Y.
enterocolitica (13) , and N. gonorrhoeae (36, 37 ) and may represent a widespread theme in bacterial adaptation to the human host. 
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